Dr Christopher Crow - Dallas, Texas 75225

Dr Christopher Crow is categorized under Doctors in Dallas, TX .

Business Name: Dr Christopher Crow
Contact Person: Christopher Crow
Address: 3609 Colgate Avenue, Dallas, Texas 75225
Phone Number: (214) 360-0649
Annual Revenue (USD): $100.000 to $499.999
Founding Year: 2006
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Doctors
SIC Code: 8011
NAICS Code: 621111
Share This Business:
Related Businesses: Shelmire David S MD - Dallas, TX 75225
Gwen Shipe MD - Dallas, TX 75225
Sandra Lotan MD - Dallas, TX 75225
Melissa D Tonn MD - Dallas, TX 75225
Rodriguez-Ruiz Martha J DO - Dallas, TX 75225
Washenik Kenneth J MD - Dallas, TX 75225
Beauchamp Cynthia MD - Dallas, TX 75225
Wenhui Cai - Dallas, TX 75225
William H Mccrae Md - Dallas, TX 75225
Neurosurgeons For Texas - Dallas, TX 75225
Peterman Joseph P MD - Dallas, TX 75225
Wheeler Jennifer L MD - Dallas, TX 75225
Pahrow & Assoc - Dallas, TX 75225
Highland Park Plastic Surgery - Dallas, TX 75225
Michael L Fawcett M D P A - Dallas, TX 75225
Thomas J Cornell M D P A - Dallas, TX 75225
Thomas L Kurt Md Pa - Dallas, TX 75225
Dr Rg Newman - Dallas, TX 75225
Oral Surgery Assoc-North Texas - Dallas, TX 75225
Andrew Portteus M D M P H , - Dallas, TX 75225

The company Dr Christopher Crow provides B2C services in the form of Doctors from its single location in Texas. 1 to 4 employees work for Dr Christopher Crow, and the business now earns $100.000 to $499.999 per annum.

Dr Christopher Crow was launched in 2006 and is classified under SIC code and category 8011 , and NAICS number and grouping 621111 . To contact Dr Christopher Crow, please call Christopher Crow with the phone number (214) 360-0649 or visit its single location at 3609 Colgate Avenue in Dallas, Texas 75225.

The location of the single location can also be found using the coordinates 32.860222,-96.793086. Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.